Company / Shareholders' Equity
aTYR PHARMA INC Shareholders' Equity History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$67.5M
FY2025
5-year range
$67.5M / $109.3M
FY2021-FY2025
Trend
-3.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Shareholders' Equity has fluctuated over the past 7 years, ranging from $32M in FY2020 to $109M in FY2021.
Based on SEC 10-K filings.
$67M in FY2025 with a 5-year CAGR of +16.3%.
Declined from $91M to $67M over the past 2 years.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- -1.9%
- 5-Year CAGR
- +16.3%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +16.3%, indicating consistent growth.
- In FY2025, shareholders' equity decreased 3.6% year-over-year.
- Peak shareholders' equity was recorded in FY2021.
- Lowest shareholders' equity in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -6.50 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $67.5M | -3.6% |
| FY2024 | $70.0M | -22.8% |
| FY2023 | $90.7M | +26.9% |
| FY2022 | $71.5M | -34.6% |
| FY2021 | $109.3M | +245.3% |
| FY2020 | $31.6M | -50.7% |
| FY2019 | $64.2M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026